Type II diabetes is a metabolic disorder that occurs when the body becomes resistant to insulin or when the pancreas fails to produce enough insulin. The result is elevated blood sugar levels, which can lead to serious health complications if not managed properly.
HonorHealth Research Institute is looking to become the first research facility in the nation to begin a new clinical trial, attempting to modify the lining of the digestive tract with the use of steam energy to control type II diabetes without the use of drugs.
The Restore-1 clinical trial involves a minimally invasive, endoscopic procedure that uses steam to refresh the mucosa, or lining, of the first several inches of the small intestine also known as the duodenum. As the mucosa grows back, patients theoretically would return to natural control of their blood-sugar. Initial research indicates that the regrown mucosa may restore patients’ digestive functions and resets the body’s control of blood sugar.
Dr. James Swain, Medical Director for the Research Institute’s Bariatrics and GI Research Division, joined “Arizona Horizon” to speak on the attempts to change the medical field for the coming future.
